Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tamoxifen”

341 trials

Showing 20 of 341 results

Testing effectiveness (Phase 2)Looking for participantsNCT06361940
What this trial is testing

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 100
Large-scale testing (Phase 3)UnknownNCT02914158
What this trial is testing

Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

Who this might be right for
Breast Cancer
First Affiliated Hospital, Sun Yat-Sen University 680
Not applicableLooking for participantsNCT04740697
What this trial is testing

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Institut Claudius Regaud 200
Large-scale testing (Phase 3)UnknownNCT05016349
What this trial is testing

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Who this might be right for
Breast Cancer Female
Mahmoud Ramadan mohamed Elkazzaz 160
Testing effectiveness (Phase 2)Study completedNCT02988986
What this trial is testing

TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast Cancer
The Methodist Hospital Research Institute 28
Large-scale testing (Phase 3)Study completedNCT03354039
What this trial is testing

Tamoxifen in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
University Hospital, Basel, Switzerland 93
Large-scale testing (Phase 3)Study completedNCT00003906
What this trial is testing

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
NSABP Foundation Inc 19,747
Testing effectiveness (Phase 2)Ended earlyNCT02322853
What this trial is testing

Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors

Who this might be right for
PostmenopausalMetastatic Breast Cancer
Centre Francois Baclesse 8
Early research (Phase 1)Study completedNCT02093351
What this trial is testing

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer

Who this might be right for
Solid Tumours
AstraZeneca 79
Large-scale testing (Phase 3)UnknownNCT00010140
What this trial is testing

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
International Collaborative Cancer Group
Early research (Phase 1)Study completedNCT02333370
What this trial is testing

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Who this might be right for
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Novartis Pharmaceuticals 88
Testing effectiveness (Phase 2)Looking for participantsNCT04765098
What this trial is testing

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Who this might be right for
Glioblastoma Multiforme
AHS Cancer Control Alberta 60
Early research (Phase 1)UnknownNCT04961632
What this trial is testing

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 75
Post-approval studies (Phase 4)Study completedNCT00649090
What this trial is testing

Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 1,549
Testing effectiveness (Phase 2)UnknownNCT05669768
What this trial is testing

Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy

Who this might be right for
Ovarian Cancer
Sun Yat-sen University 46
Not applicableStudy completedNCT01249456
What this trial is testing

Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients

Who this might be right for
Breast CancerLetrozole
Novartis Pharmaceuticals 392
Testing effectiveness (Phase 2)Study completedNCT00710970
What this trial is testing

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

Who this might be right for
Urinary Bladder Neoplasms
Seth Lerner 28
Early research (Phase 1)Study completedNCT02058381
What this trial is testing

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Pre-menopausal Breast CancerPI3K Pathway Inhibition
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)WithdrawnNCT00053339
What this trial is testing

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

Who this might be right for
Stage IV Breast CancerRecurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)Not Yet RecruitingNCT06355401
What this trial is testing

Maintenance Hormonal Therapy and DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Sohag University 100
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation